Matthias Troeltzsch
Overview
Explore the profile of Matthias Troeltzsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
482
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cagna D, Donovan T, Mckee J, Metz J, Marzola R, Murphy K, et al.
J Prosthet Dent
. 2024 Nov;
132(6):1133-1214.
PMID: 39489673
The Scientific Investigation Committee of the American Academy of Restorative Dentistry offers this review of select 2023 dental literature to briefly touch on several topics of interest to modern restorative...
2.
Brunner T, Probst F, Troeltzsch M, Schwenk-Zieger S, Zimmermann J, Morfill G, et al.
Head Face Med
. 2023 Aug;
19(1):35.
PMID: 37596585
No abstract available.
3.
Liokatis P, Obermeier K, Trautner F, Kraus M, Smolka W, Troeltzsch M, et al.
J Stomatol Oral Maxillofac Surg
. 2023 Aug;
124(6S):101594.
PMID: 37562715
Background: There is increasing evidence in the literature that alternative N-classification systems offer a simpler and more precise risk stratification than the current N- classification in patients with oral squamous...
4.
Cagna D, Donovan T, Mckee J, Eichmiller F, Metz J, Marzola R, et al.
J Prosthet Dent
. 2023 Jul;
130(4):453-532.
PMID: 37453884
The Scientific Investigation Committee of the American Academy of Restorative Dentistry offers this review of the 2022 dental literature to briefly touch on several topics of interest to modern restorative...
5.
Troeltzsch M, Zeiter S, Arens D, Nehrbass D, Probst F, Liokatis P, et al.
Medicina (Kaunas)
. 2023 May;
59(5).
PMID: 37241232
: Antiresorptive drugs are widely used in osteology and oncology. An important adverse effect of these drugs is medication-induced osteonecrosis of the jaw (MRONJ). There is scientific uncertainty about the...
6.
Cagna D, Donovan T, Mckee J, Eichmiller F, Metz J, Marzola R, et al.
J Prosthet Dent
. 2022 Sep;
128(3):248-330.
PMID: 36096911
The Scientific Investigation Committee of the American Academy of Restorative Dentistry offers this review of the 2021 dental literature in restorative dentistry to inform busy dentists regarding noteworthy scientific and...
7.
Brunner T, Probst F, Troeltzsch M, Schwenk-Zieger S, Zimmermann J, Morfill G, et al.
Head Face Med
. 2022 Jun;
18(1):21.
PMID: 35768853
Background: The aim of the present study was to examine the cytostatic effects of cold atmospheric plasma (CAP) on different head and neck squamous carcinoma (HNSCC) cell lines either in...
8.
Otto S, Schnoedt E, Troeltzsch M, Kaeppler G, Aljohani S, Liebermann A, et al.
J Oral Implantol
. 2022 Apr;
49(1):39-45.
PMID: 35446931
Medication-related osteonecrosis of the jaw (MRONJ) is a serious concern for dentists as well as maxillofacial surgeons. Therefore, the safety of dental implant placement in patient receiving antiresorptive drugs (ARDs)...
9.
Liokatis P, Malenova Y, Fegg F, Haidari S, Probst M, Boskov M, et al.
Laryngoscope Investig Otolaryngol
. 2022 Apr;
7(2):369-379.
PMID: 35434332
Objective: To evaluate the feasibility and accuracy of implementing three-dimensional virtual surgical planning (VSP) and subsequent transfer by additive manufactured tools in the secondary reconstruction of residual post-traumatic deformities in...
10.
Troeltzsch M, Kunzel V, Haidari S, Troeltzsch M, Otto S, Ehrenfeld M, et al.
J Craniomaxillofac Surg
. 2021 Dec;
50(3):281-288.
PMID: 34887169
The purpose of this study was to determine the expression patterns of specific desmosomal cadherins (desmogleins [DSG] 1/2/3) in oral squamous cell carcinoma (OSCC), and to examine possible associations with...